ReviewMolecules (Basel, Switzerland)2015
Development of Orally Active Thrombin Inhibitors for the Treatment of Thrombotic Disorder Diseases.
Li-Wei He et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it